| First Author | Zhao X | Year | 2016 |
| Journal | Cell | Volume | 165 |
| Issue | 7 | Pages | 1644-1657 |
| PubMed ID | 27238018 | Mgi Jnum | J:271692 |
| Mgi Id | MGI:6282935 | Doi | 10.1016/j.cell.2016.05.012 |
| Citation | Zhao X, et al. (2016) Circadian Amplitude Regulation via FBXW7-Targeted REV-ERBalpha Degradation. Cell 165(7):1644-1657 |
| abstractText | Defects in circadian rhythm influence physiology and behavior with implications for the treatment of sleep disorders, metabolic disease, and cancer. Although core regulatory components of clock rhythmicity have been defined, insight into the mechanisms underpinning amplitude is limited. Here, we show that REV-ERBalpha, a core inhibitory component of clock transcription, is targeted for ubiquitination and subsequent degradation by the F-box protein FBXW7. By relieving REV-ERBalpha-dependent repression, FBXW7 provides an unrecognized mechanism for enhancing the amplitude of clock gene transcription. Cyclin-dependent kinase 1 (CDK1)-mediated phosphorylation of REV-ERBalpha is necessary for FBXW7 recognition. Moreover, targeted hepatic disruption of FBXW7 alters circadian expression of core clock genes and perturbs whole-body lipid and glucose levels. This CDK1-FBXW7 pathway controlling REV-ERBalpha repression defines an unexpected molecular mechanism for re-engaging the positive transcriptional arm of the clock, as well as a potential route to manipulate clock amplitude via small molecule CDK1 inhibition. |
